Optical Coherence Tomography Market Report 2025

The optical coherence tomography market size has grown rapidly in recent years. It will grow from $1.89 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to global pandemic impact, patient preferences, competitive landscape, rapid research & development, regulatory support, miniaturization of devices.

The optical coherence tomography market size is expected to see rapid growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing healthcare expenditure, patient-centric approach, rising prevalence of eye disorders. Major trends in the forecast period include oct integration in surgeries, regulatory landscape, telemedicine and remote consultations, market competition and innovation.

The growing incidence of eye disorders is expected to boost the expansion of the optical coherence tomography market. Worldwide, conditions such as cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD) are among the leading causes of vision impairment and blindness. The rising prevalence of these eye ailments is increasing the demand for advanced diagnostic tools, including optical coherence tomography systems. For instance, according to the World Health Organization (WHO), a specialized agency of the United Nations based in Switzerland, over 2.2 billion people globally experience near- or far-vision issues due to various eye conditions, including refractive errors, cataracts, glaucoma, diabetic retinopathy, and others. Age-related macular degeneration (AMD) is ranked as the third leading cause of blindness globally, following cataracts and glaucoma. In the European Union (EU), it is estimated that AMD affects an average of 34 million people, with 22 million in just the five most populous countries. By 2050, the AMD patient population is projected to increase by 25% due to demographic growth and aging. Additionally, primary open-angle glaucoma (POAG) is expected to impact 7.32 million Americans by 2050. Therefore, the rising prevalence of eye disorders is likely to drive growth in the optical coherence tomography market.

The rising incidence of diabetes is anticipated to drive the growth of the optical coherence tomography market in the future. As diabetes becomes more prevalent worldwide, the risk of developing diabetic retinopathy, an eye condition linked to diabetes, increases. This surge in diabetes cases is leading to a higher demand for advanced diagnostic tools such as optical coherence tomography (OCT) for the early detection and monitoring of diabetic retinopathy, thus contributing to the expansion of the OCT market. For example, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported 2 million deaths attributed to diabetes. Consequently, the increasing prevalence of diabetes is fueling the growth of the optical coherence tomography market.

Technological innovations are a significant trend in the optical coherence tomography market. Leading companies are launching products with advanced technology while also introducing sophisticated solutions to enhance their revenue share, maintain competitiveness in the optical coherence tomography market, and expand their market presence. For instance, in October 2023, Abbott Laboratories, a medical device company based in the US, introduced its latest vascular imaging platform in India, featuring the Ultreon 1 Software. This software integrates optical coherence tomography (OCT) with artificial intelligence (AI) to provide physicians with a thorough evaluation of blood flow and blockages in coronary arteries. The advanced imaging software is designed to automatically distinguish between calcified and non-calcified blockages, evaluate the severity of calcium-related obstructions, and measure vessel diameter. It also aids physicians in guiding precise stent deployment, ensuring optimal expansion and apposition, while providing real-time results for improved accuracy during coronary stenting procedures. Abbott's OCT technology employs near-infrared light to deliver high-definition, precise imaging within blood vessels, allowing physicians to obtain detailed information even in complex patient anatomies.

Major players in the optical coherence tomography market are creating new imaging solutions for percutaneous coronary intervention (PCI) to secure a competitive advantage. Percutaneous Coronary Intervention is a medical procedure designed to open narrowed or blocked blood vessels in the heart, specifically the coronary arteries. For example, in June 2022, MicroPort Scientific Corporation, a medical device company based in China, launched the MicroPort Argus OCT System. This intracavitary imaging system incorporates optical coherence tomography (OCT) for high-resolution imaging, outperforming traditional methods such as digital subtraction angiography. The system automatically distinguishes between calcified and non-calcified blockages, measures vessel diameter, and assists in accurate stent deployment during coronary stenting procedures. Key features of the system include a proprietary OCT endoluminal imaging system and China's only purge-free OCT imaging catheter, heralding a new era of precision in PCI.

In July 2024, EssilorLuxottica SA, a France-based eyewear company, acquired Heidelberg Engineering, Inc. for an undisclosed sum. This acquisition aims to strengthen EssilorLuxottica's position in the med-tech sector, thereby broadening growth opportunities and raising industry standards in ophthalmic diagnostic solutions, especially in optical coherence tomography (OCT) technology. Heidelberg Engineering Inc. is a Germany-based firm that specializes in ophthalmic diagnostic imaging devices, healthcare IT, and digital surgical technology.

Major companies operating in the optical coherence tomography market are Agfa-Gevaert N.V., Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics Limited, Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Topcon Healthcare Solutions Inc., Conavi Medical Inc., ZD Medical Inc., Excelitas Technologies Corp, Thorlabs Inc., Sonostar Technologies Co. Limited, NIDEK Co. Ltd., Leica Microsystems IR GmbH, Optovue Inc., Canon Inc., Optos Inc., Santec Corporation, Tomophase Corporation, Insight Photonic Solutions Inc., Wasatch Photonics Inc., Avinger Inc., AngioDynamics Inc., BaySpec Inc., Tornado Spectral Systems Inc., Lambda Solutions Inc., LightLab Imaging Inc., Infraredx Inc., Optoprobe Inc., Terumo Corporation, Optiscan Pty Ltd., NinePoint Medical Inc., Axsun Technologies Inc., AOT AG.

North America was the largest region in the optical coherence tomography market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical coherence tomography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the optical coherence tomography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Optical coherence tomography (OCT) stands as a highly effective imaging technology in medical diagnostics, functioning akin to an optical biopsy. Its real-time, in situ tissue imaging capability proves instrumental in delivering precise insights. OCT specializes in delivering high-resolution cross-sectional images, revolutionizing diagnostic processes.

Various iterations of optical coherence tomography devices cater to specific medical needs. These include catheter-based, doppler, handheld, and tabletop OCT devices. Catheter-based OCT, specifically designed for imaging coronary arteries, is pivotal for patients qualifying for transluminal interventional procedures. These specialized catheters are engineered for vessels with diameters ranging from 2 to 3.5 mm. Optical coherence tomography incorporates diverse technologies like time domain OCT (TDOCT), frequency domain OCT (FD-OCT), and spatial encoded frequency domain OCT. This array of technologies finds broad applications across fields such as ophthalmology, cardiovascular medicine, oncology, dermatology, and various other specialized domains, transforming diagnostic capabilities in these sectors.

The optical coherence tomography market research report is one of a series of new reports that provides optical coherence tomography market statistics, including optical coherence tomography industry global market size, regional shares, competitors with an optical coherence tomography market share, detailed optical coherence tomography market segments, market trends and opportunities, and any further data you may need to thrive in the optical coherence tomography industry. This optical coherence tomography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The optical coherence tomography market consists of revenues earned by entities by Fourier Domain OCT (FDOCT). The market value includes the value of related goods sold by the service provider or included within the service offering. The optical coherence tomography market also includes sales of OCT devices which are used in providing optical coherence tomograph services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.